Constipation in adults with neurofibromatosis type 1

dc.contributor.author Klaus Krogh
dc.contributor.author Cecilie Ejerskov
dc.contributor.author Cecilie Ejerskov
dc.contributor.author John R. Østergaard
dc.contributor.author Janne Fassov
dc.contributor.author Annette Haagerup
dc.date.accessioned 2025-06-17T20:45:51Z
dc.date.available 2025-06-17T20:45:51Z
dc.date.issued 2017-08-16
dc.description.abstract Neurofibromatosis type 1 (NF1) is an autosomal-dominant disease characterised by symptoms of the skin, eyes, nervous system and bones. A previous study indicated that constipation, large rectal diameters and prolonged colorectal transit times are common in children with NF1. The aim of the present study was to investigate and compare the prevalence of gastrointestinal symptoms in adult patients with NF1 to their unaffected relatives serving as the control group. Patients with NF1 were recruited from one of two Danish National Centres of Expertise for NF1 and their unaffected relatives were invited to participate as controls. Gastrointestinal symptoms were assessed with a web-based, self-administered, validated, Rome® III diagnostic questionnaire. Logistic regression was used to estimate the prevalence of functional dyspepsia, IBS and functional constipation in each group and the groups were compared using their odds ratios.The response rates for patients and controls were 66.4% and 82.4%, respectively. We compared 175 patients, median age 34.2 (IQR = 20.1) and 91 of their unaffected relatives, median age 42.0 (IQR = 12). The overall likelihood of fulfilling the diagnostic criteria for functional constipation, irritable bowel syndrome or functional dyspepsia was 33.1% among patients vs. 14.3% among controls, (odds ratio (OR): 2.97; 95% CI: 1.56-5.66) and after adjustment for age and gender (OR: 3.06; 95% CI: 1.62-5.79). The likelihood of functional constipation was higher among patients (OR: 3.80; 95% CI: 1.27-11.31), and this was still true after adjustment (OR: 3.49; 95% CI: 1.14-10.64). The likelihood of irritable bowel syndrome (OR: 2.29; 95% CI: 0.98-5.33) was evident after adjustment (OR: 2.46; 95% CI: 1.10-5.47), whereas there was no difference in the likelihood of functional dyspepsia (OR: 2.35; 95% CI: 0.67-8.32) after adjustment (OR:2.25; 95% CI: 0.70-7.17).Overall, having symptoms usually attributed to either functional dyspepsia, IBS or functional constipation is more common in adults with NF1 compared to unaffected relatives. Of the three, the likelihood of constipation is markedly higher. The high prevalence of constipation indicates that it is not functional but part of the NF1 disorder.
dc.description.volume 12
dc.identifier.doi 10.1186/s13023-017-0691-4
dc.identifier.issn 1750-1172
dc.identifier.openaire doi_dedup___:9c05d9422531ea78bd53201dc47c04a7
dc.identifier.pmc PMC5559807
dc.identifier.pmid 28814319
dc.identifier.uri https://ror.circle-u.eu/handle/123456789/892864
dc.openaire.affiliation Aarhus University
dc.openaire.collaboration 1
dc.publisher Springer Science and Business Media LLC
dc.rights OPEN
dc.source Orphanet Journal of Rare Diseases
dc.subject Adult
dc.subject Male
dc.subject Neurofibromatosis 1
dc.subject Adolescent
dc.subject Gastrointestinal Diseases
dc.subject Functional gastrointestinal disorders
dc.subject Irritable Bowel Syndrome
dc.subject Young Adult
dc.subject Risk Factors
dc.subject Surveys and Questionnaires
dc.subject Journal Article
dc.subject Humans
dc.subject Dyspepsia
dc.subject Research
dc.subject R
dc.subject Middle Aged
dc.subject Self-report questionnaire
dc.subject Irritable bowel syndrome
dc.subject Logistic Models
dc.subject Medicine
dc.subject Female
dc.subject Functional constipation
dc.subject Constipation
dc.subject Neurofibromatosis type 1
dc.subject Rome criteria
dc.subject.fos 0301 basic medicine
dc.subject.fos 03 medical and health sciences
dc.subject.sdg 3. Good health
dc.title Constipation in adults with neurofibromatosis type 1
dc.type publication

Files

Collections